This roundup is revealed month-to-month. It’s meant to focus on a few of healthcare’s latest hiring information and isn’t supposed to be complete. When you’ve got information about an government appointment, resignation or layoff that you just want to share for this roundup, please attain out to [email protected].
Hires
Breyer Capital appointed Bret Bostwick as its new enterprise advisor. He just lately served as a senior medical director at Alnylam Prescribed drugs, the place he co-invented a number of RNAi therapeutics. Earlier than that, he labored as chief of pediatric genetics at Texas Youngsters’s Hospital.
Cone Well being named Paul Krakovitz as its new CEO. Krakovitz, who will step into the brand new function in March, at the moment serves as government in residence at personal fairness agency Cressey & Firm. Previous to that, he held management roles at Intermountain Well being and Cleveland Clinic.
DexCare, a startup providing well being methods a platform to assist them coordinate and handle digital care, welcomed Rakshay Jain as chief product officer. He joins the corporate from Innovaccer, the place he most just lately served as vp of product administration.
Tracy Beth Høeg turned the brand new director of the FDA’s Heart for Drug Analysis and Analysis — marking the fifth individual appointed to steer the middle in 2025. She is a sports activities drugs doctor who joined the company in March as particular assistant to the commissioner.
Coronary heart Rhythm Society appointed Christina Wurster as its new CEO. Wurster, who will assume the place in March, at the moment serves as CEO of the Society for Maternal-Fetal Medication, a task she has held since 2021. Earlier than that, she spent greater than 12 years in management roles at Coronary heart Rhythm Society.
Thomas Carlough joined companion care firm Papa as its new chief know-how officer. Up to now, he labored for greater than a decade at Atlantic Well being System, serving largely in medical analytics management roles.
Worth-based kidney care firm Try Well being welcomed Keith Bellovich as its new chief nephrologist. He joins the corporate from Henry Ford Well being, the place he served most just lately as chief medical officer of the Detroit-based well being system’s St. John Hospital.
Promotions
Neighborhood Well being Programs (CHS), one of many largest for-profit well being methods within the nation, appointed Kevin Hammons as its new everlasting CEO and Jason Johnson as its new CFO. Each executives had been serving in interim roles since October. Hammons first joined CHS in 1997 and has served in a number of management roles since, primarily in monetary administration. Johnson joined the well being system in 2012 as vp and assistant company controller.
The Federation of American Hospitals named Charlene MacDonald as its new CEO. She joined the group in 2023 as its government vp of public affairs. Previous to working at FAH, she held management roles at CareFirst BlueCross BlueShield and FTI Consulting, in addition to spent practically 10 years in senior coverage positions within the U.S. Home of Representatives and Senate.
Exits
Rick Pollack, CEO of the American Hospital Affiliation, introduced his plan to retire by the top of 2026. He spent 43 years on the group — together with greater than a decade as its CEO.
Layoffs
Northern California-based Alameda Well being System plans to put off 296 staff throughout varied departments, together with medical care, administration and help. The well being system stated the job cuts are a results of tens of millions of {dollars} of misplaced income stemming from the Trump administration’s One Large Stunning Invoice Act.
Vibra Specialty Hospital of Portland will shut in February and let go of greater than 300 staff as a result of monetary challenges.
Intercept Prescribed drugs introduced plans to slash 146 jobs in New Jersey following the voluntary withdrawal of its solely business drug, Ocaliva, from the U.S. market.
To chop prices, Pfizer is lowering its workforce in Switzerland from about 300 staffers to roughly 70 by the top of 2025.
Voyager Therapeutics laid off 30 staff. This adopted its companion Novartis‘ resolution to discontinue two discovery-stage gene remedy applications below their collaboration.
